• Effectiveness matters: screening for prostate cancer. NHS centre for reviews and dissemination, Vol. 2, Issue 2, Feb.
  • 2
    CA-Cancer Statistics. 1996. Atlanta, Georgia. Am Cancer Soc 1996; 46: 527
  • 3
    Cooner WH, Mosley BR, Rutherford Cl et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 114654
  • 4
    Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994; 151: 128390
  • 5
    Masters JG, Keegan PE, Hildreth AJ, Greene DR. Free/total serum prostate specific antigen ratio: how helpful is it in detecting prostate cancer? Br J Urol 1998; 81: 41923
  • 6
    Selzman AA, Resnick MI. Transrectal ultrasound and prostate biopsy. Semin Urol 1994; 12: 26573
  • 7
    Fleshner NE, O’Sullivan M, Fair WF. Prevalence and predictors of a positive repeat transrectal ultrasound-guided needle biopsy of the prostate. J Urol 1997; 158: 5059
  • 8
    Roehrborn CG, Pickens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathological diagnoses and prostate specific antigen levels. Urology 1996; 47: 34752
  • 9
    Ellis JW, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995; 153: 14968
  • 10
    Keetch DW, Catalona WJ, Smith DS. Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994; 151: 15714
  • 11
    Eskew AL, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199203
  • 12
    Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998; 159: 4716
  • 13
    Chen ME, Trancoso P, Johnston DA, Tang K, Babaian RJ. Optimisation of prostate biopsy strategy using computer based analysis. J Urol 1997; 158: 216875
  • 14
    Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided transition zone biopsy in the detection of prostate cancer. J Urol 1995; 153: 10003
  • 15
    Epstein JI, Walsh PC, Sauvageot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol 1997; 158: 188690
  • 16
    Bazinet M, Karakiewicz PI, Aprikian AG et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 1996; 155: 6056
  • 17
    Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 1995; 154: 17957
  • 18
    Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostate biopsies. J Urol 1996; 156: 42831
  • 19
    Thiel RP, Oesterling JE, Wojno KJ et al. Multicenter comparison of the diagnostic performance of free prostate specific antigen. Urology 1996; 48: 4550
  • 20
    Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW. Prospective use of free prostate specific antigen to avoid repeat prostate biopsies in men with elevated total prostate specific antigen. Urology 1996; 48: 7680
  • 21
    Catalona WJ, Beiser JA, Smith DS. Serum prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 1997; 158: 21627